Vimarsana
Biggest News Aggregation in the World

Page 5 - Multiple System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple System Today - Breaking & Trending Today

Kimberly L. Seman - Vimarsana News

Kimberly L. Seman

MIDDLEBURY — Kimberly L. Seman, 57, of Middlebury, entered into heaven on Saturday, November 11, 2023, after a courageous six-year battle with Multiple System Atrophy.

AskBio Announces First Patient Randomized in Phase 1 Trial of AB-1005 (AAV2-GDNF) Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P) - Vimarsana News

AskBio Announces First Patient Randomized in Phase 1 Trial of AB-1005 (AAV2-GDNF) Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)

Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels in the brain for the treatment ...

Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 - Vimarsana News

Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434

MELBOURNE, Australia and SAN FRANCISCO, Nov. 16, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...

Alterity Therapeutics : Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 -November 15, 2023 at 05:54 pm EST - Vimarsana News

Alterity Therapeutics : Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 -November 15, 2023 at 05:54 pm EST

Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 November 16, 2023November 16, 2023 Alterity Therapeutics ...

Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period ... - Vimarsana News

Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period ...

BOSTON and ATLANTA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course